ClinicalTrials.Veeva

Menu

High-flow Nasal Cannula Oxygen Therapy for Ischemic Stroke Patients With Dysphagia and Obstructive Sleep Apnea

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Cerebral Infarction
Sleep Apnea, Obstructive
Deglutition Disorders

Treatments

Device: high flow nasal cannula ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT04173767
CMRPG2H0011

Details and patient eligibility

About

High flow nasal cannula (HFNC) ventilation therapy was found to improve the severity of obstructive sleep apnea in non-stroke subjects. The investigators hypothesized that HFNC might be effective in stroke patients with dysphagia who needed nasogastric tube feeding and can not receive continuous positive airway pressure ventilation for obstructive sleep apnea.

Enrollment

22 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ischemic stroke patients with dysphagia and obstructive sleep apnea who need nasogastric tube feedings

Exclusion criteria

  • congestive heart failure, unconsciousness, chronic obstructive pulmonary disease, intracranial hemorrhage or malignancy, and unstable medical and neurological conditions
  • central sleep apnea

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 1 patient group

HFNC
Experimental group
Treatment:
Device: high flow nasal cannula ventilation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems